Detection of anti-drug antibodies during monoclonal antibody drug therapy
Trends in Biotechnology · 2026-05
DOI: 10.1016/j.tibtech.2026.04.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2026-05. Verfasst von Frans Kokojka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology Engineering, Faculty of Engineering Science, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electronic a…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: The Leona M and Harry B Helmsley Charitable Trust, Israel Innovation Authority.
Abstract (Originalsprache)
Therapeutic monoclonal antibodies can elicit anti-drug antibodies (ADAs) in patients, which impact drug pharmacokinetics, reduce efficacy, and occasionally cause hypersensitivity reactions. Growing evidence indicates that early detection of ADA responses improves therapy outcomes, yet their monitoring has remained underappreciated. Conventional assays are complex, time-consuming, and confined to centralized laboratories, thereby delaying clinical decisions. In contrast, emerging biosensor technologies represent a promising alternative for timely, on-site ADA detection. This review examines advancements in ADA detection and provides a critical overview of its clinical relevance based on contemporary findings. Furthermore, the challenges and complexities of accurately biosensing ADAs are discussed. Finally, we explore the prospects of biosensors for on-site analysis and their integration into proactive therapeutic drug monitoring.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology Engineering, Faculty of Engineering Science, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electronic address: fransk@post.bgu.ac.il.
- Nanomedicines and Nanoprobes Department, Center for Molecular Biophysics, UPR CNRS 4301, University of Tours, Tours, France.
- Department of Biotechnology Engineering, Faculty of Engineering Science, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electronic address: rsmarks@bgu.ac.il.
Förderung
- The Leona M and Harry B Helmsley Charitable Trust
- Israel Innovation Authority
Zitieren
APA
Kokojka, F., Mulleman, D., & Marks, R. S. (2026). Detection of anti-drug antibodies during monoclonal antibody drug therapy. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.04.003
Vancouver
Kokojka F, Mulleman D, Marks RS. Detection of anti-drug antibodies during monoclonal antibody drug therapy. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.04.003
BibTeX
@article{Kokojka2026,
author = {Kokojka, Frans and Mulleman, Denis and Marks, Robert S},
title = {Detection of anti-drug antibodies during monoclonal antibody drug therapy},
journal = {Trends in Biotechnology},
year = {2026},
doi = {10.1016/j.tibtech.2026.04.003}
}
EUVIMED